11/12/24 16:08 | 11/8/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -7,827 | 515.00 | 0 | -15 | -17 | 76 | D | | | | | | | | | | | | | | |
8/1/24 16:17 | 7/30/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -7,677 | 505.00 | 0 | -15 | -14 | 91 | D | | | | | | | | | | | | | | |
7/24/24 16:05 | 7/22/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -7,555 | 497.00 | 0 | -15 | -13 | 106 | D | | | | | | | | | | | | | | |
6/14/24 16:24 | 6/12/24 | DNA | Ginkgo Bioworks Holdings, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kewalramani Reshma | MA | D | | M.d | 0 | 0.00 | 0 | 105 | 130 | 186 | D | | | | | | | | | | | | | | |
5/29/24 16:08 | 5/24/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | M.d | 293 | 187.53 | 0 | 2 | 1 | 121 | D | | | | | | | | | | | | | | |
5/29/24 16:08 | 5/24/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S.d | -715 | 457.00 | 0 | -2 | -1 | 121 | D | | | | | | | | | | | | | | |
5/22/24 16:21 | 5/20/24 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -6,795 | 447.00 | 0 | -15 | -11 | 121 | D | | | | | | | | | | | | | | |
12/19/23 16:15 | 12/15/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | M.d | 3,116 | 181.83 | 0 | 17 | 19 | 109 | D | | | | | | | | | | | | | | |
12/19/23 16:15 | 12/15/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S.d | -6,974 | 407.00 | 0 | -17 | -14 | 109 | D | | | | | | | | | | | | | | |
12/15/23 16:23 | 12/13/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -2,024 | 397.00 | 0 | -5 | -4 | 109 | D | | | | | | | | | | | | | | |
11/15/23 16:16 | 11/13/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -1,922 | 377.00 | 0 | -5 | -4 | 114 | D | | | | | | | | | | | | | | |
7/18/23 16:13 | 7/17/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -2,779 | 355.00 | 0 | -8 | -6 | 119 | D | | | | | | | | | | | | | | |
5/1/23 16:26 | 4/27/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -1,125 | 339.08 | 0 | -3 | -3 | 127 | D | | | | | | | | | | | | | | |
1/27/23 16:13 | 1/25/23 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -3,151 | 315.05 | 0 | -10 | -10 | 90 | D | | | | | | | | | | | | | | |
11/10/22 17:30 | 9/30/22 | DNA | Ginkgo Bioworks Holdings, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kewalramani Reshma | MA | D | | M.d | 0 | 0.00 | 0 | 10 | 14 | 81 | D | | | | | | | | | | | | | | |
8/17/22 17:40 | 8/15/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -3,566 | 305.06 | 0 | -12 | -11 | 100 | D | | | | | | | | | | | | | | |
6/28/22 16:05 | 6/24/22 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -3,405 | 291.30 | 0 | -12 | -10 | 111 | D | | | | | | | | | | | | | | |
8/23/21 08:30 | 8/19/21 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | P | 1,956 | 195.65 | 0 | 10 | 16 | 74 | D | | | | | | | | | | | | | | |
8/10/20 16:19 | 8/6/20 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | M.d | 372 | 179.68 | 0 | 2 | 8 | 27 | D | | | | | | | | | | | | | | |
8/10/20 16:19 | 8/6/20 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S.d | -562 | 271.20 | 0 | -2 | -7 | 27 | D | | | | | | | | | | | | | | |
5/19/20 16:35 | 5/15/20 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S | -28 | 284.17 | 0 | 0 | 0 | 27 | D | | | | | | | | | | | | | | |
5/8/20 16:19 | 5/6/20 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | M.d | 373 | 179.67 | 0 | 2 | 8 | 27 | D | | | | | | | | | | | | | | |
5/8/20 16:19 | 5/6/20 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | CEO,P | S.d | -566 | 272.85 | 0 | -2 | -7 | 27 | D | | | | | | | | | | | | | | |
2/26/20 16:32 | 2/25/20 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | EVP,CMO | S | -848 | 233.45 | 0 | -4 | -12 | 27 | D | | | | | | | | | | | | | | |
2/19/20 16:33 | 2/18/20 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | DO | EVP,CMO | S | -288 | 243.51 | 0 | -1 | -3 | 33 | D | | | | | | | | | | | | | | |
2/7/20 16:14 | 2/6/20 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | M.d | 373 | 179.67 | 0 | 2 | 6 | 35 | D | | | | | | | | | | | | | | |
2/7/20 16:14 | 2/6/20 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | S.d | -497 | 239.44 | 0 | -2 | -6 | 35 | D | | | | | | | | | | | | | | |
11/26/19 16:12 | 11/25/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | M.d | 880 | 187.53 | 0 | 5 | 56 | 13 | D | | | | | | | | | | | | | | |
11/26/19 16:12 | 11/25/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | S.d | -1,029 | 219.37 | 0 | -5 | -26 | 13 | D | | | | | | | | | | | | | | |
11/19/19 16:11 | 11/15/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | S | -13 | 205.95 | 0 | 0 | 0 | 13 | D | | | | | | | | | | | | | | |
11/13/19 16:08 | 11/8/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | M.d | 79 | 155.57 | 0 | 1 | 4 | 13 | D | | | | | | | | | | | | | | |
11/13/19 16:08 | 11/8/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | S.d | -101 | 199.00 | 0 | -1 | -4 | 13 | D | | | | | | | | | | | | | | |
10/31/19 16:36 | 10/30/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | M.d | 476 | 155.57 | 0 | 3 | 30 | 13 | D | | | | | | | | | | | | | | |
10/31/19 16:36 | 10/30/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | S.d | -608 | 199.00 | 0 | -3 | -19 | 13 | D | | | | | | | | | | | | | | |
10/24/19 19:18 | 10/22/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | S | -121 | 189.00 | 0 | -1 | -5 | 13 | D | | | | | | | | | | | | | | |
5/17/19 16:21 | 5/15/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | S | -40 | 165.41 | 0 | 0 | -2 | 14 | D | | | | | | | | | | | | | | |
2/21/19 16:22 | 2/19/19 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | S | -278 | 186.94 | 0 | -1 | -10 | 14 | D | | | | | | | | | | | | | | |
10/9/18 16:50 | 10/8/18 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | Kewalramani Reshma | MA | O | EVP,CMO | S | -431 | 186.95 | 0 | -2 | -55 | 2 | D | | | | | | | | | | | | | | |